GlaxoSmithKline Pharmaceuticals Ltd. - Research Center
500660 GLAXO Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 3,407.25 | 3,216.34 | 3,217.51 | 2,920.48 | 3,224.68 |
| Expenses | |||||
| Material consumed | 1,296.04 | 1,255.99 | 1,300.39 | 1,252.47 | 1,308.95 |
| Manufacturing expenses | 29.64 | 103.44 | 121.30 | 108.04 | 33.36 |
| Personnel expenses | 624.39 | 594.99 | 610.23 | 616.16 | 628.55 |
| Selling expenses | - | - | - | - | 138.23 |
| Adminstrative expenses | 556.53 | 462.50 | 429.76 | 346.03 | 457.13 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 2,506.60 | 2,416.92 | 2,461.68 | 2,322.70 | 2,566.23 |
| Operating profit | 900.65 | 799.43 | 755.83 | 597.77 | 658.45 |
| Other recurring income | 123.48 | 101.51 | 76.22 | 110.19 | 77.56 |
| Adjusted PBDIT | 1,024.13 | 900.94 | 832.04 | 707.96 | 736.01 |
| Financial expenses | 1.80 | 1.81 | 1.99 | 3.53 | 6.34 |
| Depreciation | 69.68 | 65.77 | 68.19 | 78.60 | 82.68 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 952.65 | 833.36 | 761.87 | 625.83 | 646.99 |
| Tax charges | 224.35 | 227.69 | 396.87 | 166.54 | 212.45 |
| Adjusted PAT | 728.30 | 605.67 | 365.00 | 459.29 | 434.55 |
| Non recurring items | -143.62 | 2.08 | 1,325.53 | -101.72 | -324.49 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 584.69 | 607.75 | 1,690.53 | 357.57 | 110.05 |
| Earnigs before appropriation | 1,412.81 | 2,352.77 | 2,253.24 | 1,240.34 | 1,291.23 |
| Equity dividend | 542.10 | 1,524.66 | 508.22 | 677.62 | 269.17 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 69.64 |
| Retained earnings | 870.71 | 828.12 | 1,745.02 | 562.71 | 952.41 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis